These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 16190395)
1. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases]. Wu SJ; Chen P; Jiang XN; Liu ZJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395 [TBL] [Abstract][Full Text] [Related]
2. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation]. Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817 [TBL] [Abstract][Full Text] [Related]
3. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection. Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388 [TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197 [TBL] [Abstract][Full Text] [Related]
6. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413 [TBL] [Abstract][Full Text] [Related]
7. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. Baldi S; Ruffini E; Harari S; Roviaro GC; Nosotti M; Bellaviti N; Venuta F; Diso D; Rea F; Schiraldi C; Durigato A; Pavanello M; Carretta A; Zannini P J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1616-22. PubMed ID: 16308007 [TBL] [Abstract][Full Text] [Related]
8. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation]. Zhang J; Yao WZ; Sun YC Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960 [TBL] [Abstract][Full Text] [Related]
9. [Changes of the activity and expression of gamma-glutamylcysteine synthetase in patients with chronic obstructive pulmonary disease]. Lin SD; Dai AG; Xu P Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):97-101. PubMed ID: 15854390 [TBL] [Abstract][Full Text] [Related]
10. [Clinical observation and expression of C-reactive protein by LPS-induced A549 cells in patients with chronic obstructive pulmonary disease]. Wu SJ; Zhao SP Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):207-10. PubMed ID: 15898436 [TBL] [Abstract][Full Text] [Related]
11. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients. Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730 [TBL] [Abstract][Full Text] [Related]
12. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638 [TBL] [Abstract][Full Text] [Related]
13. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322 [TBL] [Abstract][Full Text] [Related]
14. [Elevated substance P content in sputum and plasma in patients with COPD and its relationship with FEV1/FVC]. Tian L; Cai L; Kang J Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):138-40. PubMed ID: 11778483 [TBL] [Abstract][Full Text] [Related]
15. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases. Majumdar S; Sen S; Mandal SK J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952 [TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Karadag F; Kirdar S; Karul AB; Ceylan E Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305 [TBL] [Abstract][Full Text] [Related]
17. Circulating visfatin in chronic obstructive pulmonary disease. Liu X; Ji Y; Chen J; Li S; Luo F Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239 [TBL] [Abstract][Full Text] [Related]
18. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease]. Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526 [TBL] [Abstract][Full Text] [Related]
19. Association of oxidative stress markers and C-reactive protein with multidimensional indexes in COPD. Folchini F; Nonato NL; Feofiloff E; D'Almeida V; Nascimento O; Jardim JR Chron Respir Dis; 2011; 8(2):101-8. PubMed ID: 21436222 [TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels in the serum of asthmatic patients. Fujita M; Ueki S; Ito W; Chiba T; Takeda M; Saito N; Kayaba H; Chihara J Ann Allergy Asthma Immunol; 2007 Jul; 99(1):48-53. PubMed ID: 17650829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]